Zantac
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
Class-Action Tracker
The Latest
Court Cancels ‘Click-to-Cancel’ Rule
It won’t get any easier to cancel those annoying subscriptions.
Ribena – There’s No Taste Like Home
This soft drink reminds consumers of the good old days.
US Cellular: ‘Four Free Phones and Four Lines for $90’
What you need to know about this offer.
Monetizing Minors: Aneliese German (aka Lisi Shops)
What’s this kidfluencer doing promoting a “youth cream”?
This Secretive Company Built An Empire By Hawking Bad Financial And Health Advice On Facebook
Emily Baker-White, Forbes